Technetium-99m Generators

Molybdenum-99 (Mo-99) is used to produce Technetium-99 metastable (Tc-99m), one of the most prevalently used diagnostic imaging agents in nuclear medicine to help detect illnesses like cancer and heart disease.

Our scientists and engineers have developed a Tc-99m generator to meet the long-term, stable supply for diagnostic imaging. Featuring a patent-pending neutron capture process, this innovative technology is designed to produce molybdenum-99 (Mo-99), the parent isotope of Technetium-99m (Tc-99m), which is used in over 40 million medical procedures across the globe each year.

What makes our technology different?

Historically, Mo-99 has been produced within research reactors using uranium as a starting material. But our new proprietary technology features:

• A neutron capture process that will use molybdenum, rather than uranium, targets (mitigating radioactive waste streams and nuclear proliferation concerns)
• Irradiation of molybdenum targets at commercial power reactors
• A process to convert low-specific-activity Mo-99 into technetium generators that perform the same as other generators on the market (i.e., offering the same activity, quality, and method of elution)